Stock market numbers are displayed on a screen at the New York Stock Exchange during afternoon trading on August 02, 2024 in New York City. Stocks closed low after the July jobs report showed a slowdown in the labour market, with the Dow Jones closing with a loss of over 600 points after being nearly down 1000 points and Nasdaq closing at a loss of over 400 points.
The S&P 500's 16% gain in 2025 was built on a narrow foundation. Five technology stocks accounted for nearly half of the index's total return, according to CFRA data. The other 495? Mostly bystanders. This dynamic extended into the first quarter of 2026, with Nomura analysts finding that just 10 stocks drove 69% of the index's gains during a 28-session rally from late March to early May. That kind of concentration, though not new, is historically associated with mean reversion — and 2026 may finally be the year that reversion shows up in the small- and mid-cap segment.
The evidence of a shift is early but real. According to a May 2026 Money report, micro-cap stocks have outperformed the 500 largest U.S.-listed stocks year-to-date, with market volatility favouring smaller, more nimble companies. The Russell 2000 has posted a 4.6% single-day gain at least once this spring in response to positive macro data, suggesting that the index is coiled for movement when catalysts arrive. Goldman Sachs chief equity strategist David Kostin has publicly noted that "high concentration today portends much lower S&P 500 returns over the next decade," implicitly making the case that capital will need to find other homes.
The Valuation Argument
Small- and mid-cap stocks are not cheap in an absolute sense — almost nothing in U.S. equities is cheap in an absolute sense right now. But they are cheap relative to large caps in a way that is historically unusual. The S&P 500 cap-weighted index outperformed its equal-weighted counterpart by roughly 32% over the prior three years, according to RBC Wealth Management's January 2026 analysis. That gap is historically extreme. From 2003 through 2022 — a 19-year period — the equal-weighted index actually outperformed the cap-weighted index by roughly 1.5% per year, reflecting size effects and periodic mean reversion among large-cap leaders. The magnitude of recent underperformance by small- and mid-cap names suggests that the relative valuation discount has room to normalize significantly.
The forward P/E for the Russell 2000 sits at a material discount to the S&P 500 by most measures. For investors who believe that earnings growth will broaden beyond the Magnificent Seven into industrials, financials, healthcare, and consumer sectors in the back half of 2026 — a view supported by FactSet's estimate of 14.5% S&P 500 EPS growth for the full year — small- and mid-caps are the more leveraged way to play that broadening without paying current large-cap multiples.
The Rate and Credit Cycle Connection
Small-cap stocks are more sensitive to interest rates and credit conditions than large-caps, for a straightforward structural reason: smaller companies rely more heavily on external capital markets. A significant percentage of Russell 2000 companies carry floating-rate debt, which means that their interest expense moves directly with short-term rate changes. The Fed's easing cycle, which has brought the target range from its 5.25-5.50% peak to the current 3.50-3.75%, has materially reduced debt service costs for these companies. Every additional 25 basis point cut — and the market is pricing approximately 50 more basis points by year-end — provides further relief.
The quality distinction within the small- and mid-cap universe matters here. Oppenheimer's 2026 market outlook drew an explicit line between high-quality SMID-cap stocks and lower-quality names, noting that higher-quality businesses "have less debt and are less burdened by higher borrowing costs" and can "better navigate tariffs by passing through price increases or shifting supply chains." The lesson of 2023 and 2024, when rate-sensitive small-cap junk got crushed but quality SMID held up, is that indiscriminate index exposure to the Russell 2000 is not the same as thoughtful SMID-cap selection. The index contains a substantial number of unprofitable or marginally profitable companies that remain rate-sensitive in ways that argue for active management or factor-focused index approaches.
M&A and the Catalyst Calendar
One underappreciated driver for small- and mid-cap outperformance in 2026 is the M&A environment. Goldman Sachs's 2026 outlook flagged an expected recovery in global dealmaking, with private equity activity and strategic corporate acquisitions both expected to accelerate. Small- and mid-cap stocks are the primary hunting ground for acquirers, and the combination of compressed valuations and a more permissive regulatory environment under the current administration creates conditions that historically drive M&A-related premiums.
The deregulatory policy stance — across banking, energy, technology, and healthcare — has reduced the deal risk that suppressed M&A volumes in 2022 through 2024. Private equity firms that sat on large uninvested capital pools through the high-rate environment are now deploying. Strategic buyers in technology, healthcare, and industrials are using their elevated equity currency to make acquisitions. For small- and mid-cap shareholders, each announced deal is a repricing catalyst for the broader peer group, as investors reassess what comparably positioned companies might be worth in a takeout scenario.
The Risks Are Real
None of this means small- and mid-cap stocks are a one-way trade. A recession scenario — still assigned roughly a 20-25% probability by most economic forecasters — would disproportionately hurt smaller companies with less pricing power and thinner balance sheets. A geopolitical shock that drives a flight to quality would likely benefit large-cap defensives over SMID. And if the Fed pauses or reverses its easing path because of inflation resurgence — a real risk given the energy dynamics described elsewhere — the credit environment for smaller companies could deteriorate quickly.
The case for SMID-cap exposure in a balanced portfolio is not that it is without risk. It is that the risk reward has shifted in its favour after three years of extreme underperformance and that the cyclical and structural tailwinds — rate relief, broadening earnings, M&A activity, relative valuation discount — are aligned in a way that argues for at least a tactical overweight from investors who have been crowded into large-cap growth for too long.
This article was written by Jason Kirsch from Forbes and was legally licensed through the DiveMarketplace by Industry Dive. Please direct all licensing questions to legal@industrydive.com.